MentionFox
Home › Who owns › Intellia Therapeutics, Inc.
Owners, funding and legal record

Who owns Intellia Therapeutics, Inc.? Owners, funding and legal record

Before you sign with, sell to or invest in Intellia Therapeutics, Inc.

MentionFox check on Intellia Therapeutics, Inc.: no red flags found in 13 sources; 1 item to note (checked 15 November 2026). mentionfox.com/c/who-owns/intellia-therapeutics

  • Note: Layoff plan disclosed Jan 2025 (filing)

New since last check: Layoff plan disclosed Jan 2025 (filing, first seen 14 November 2026).

Check Intellia Therapeutics, Inc. before you sign, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Intellia Therapeutics, Inc.?

Intellia Therapeutics, Inc. is a publicly traded company (Nasdaq: NTLA). The most recent 5%+ ownership report names State Street holding 5.6% (Schedule 13G, filed 2026-11-10).

As of November 15, 2026, Intellia Therapeutics, Inc. is a publicly traded company (Nasdaq: NTLA); its largest reported holder is ARK Invest, with 12.27% on Schedule 13G/A of February 3, 2026, then State Street (5.6%). The largest insider holding is John M. Leonard, the chief executive and president, with 1,196,479 shares (0.85% of shares outstanding), per Form 4 of November 3, 2026 (Schedule 13G/A, February 3, 2026).

Contrarius Investment Management Ltd also filed stake reports on 1 other company ↓

Is this your company?

About to sign with, pay or invest in Intellia Therapeutics, Inc.? See the free Snapshot first.

Watch Intellia Therapeutics, Inc.

Free to see. No signup.

Is Intellia Therapeutics, Inc. a real, registered company?

Before you sign or pay

Who are Intellia Therapeutics, Inc.'s owners and officers?

Intellia Therapeutics, Inc.: incorporated in Delaware; business address in Cambridge, Massachusetts; industry In Vitro & In Vivo Diagnostic Substances (Schedule 13G, 2026-11-10).

ReportHolderShare
Schedule 13G, 2026-11-10State Street Corporation5.6%
Schedule 13G, 2026-08-07State Street Corporation6.8%
Schedule 13G, 2026-04-30Vanguard Capital Management5.03%
Schedule 13G, 2026-04-29Vanguard Portfolio Management5.3%
Schedule 13G/A, 2026-03-27The Vanguard Group0%
Schedule 13G/A, 2026-02-12The Goldman Sachs Group, Inc.2.7%
Schedule 13G/A, 2026-02-11Contrarius Investment Management LTD0.6%
Schedule 13G, 2026-02-09State Street Corporation5.5%
Schedule 13G/A, 2026-02-03Ark Investment Management LLC12.27%
Schedule 13G/A, 2026-01-30The Vanguard Group11.23%
Schedule 13G, 2025-11-12The Goldman Sachs Group, Inc.5.1%
Schedule 13G, 2025-11-12Contrarius Investment Management LTD5.5%

Questions about who owns Intellia Therapeutics, Inc.

Who owns Intellia Therapeutics, Inc.?

On this page, 4 holders' latest ownership filings report 5% or more of Intellia Therapeutics, Inc.: Ark Investment Management LLC (12.27%, Schedule 13G/A, filed 2026-02-03), State Street Corporation (5.6%, Schedule 13G, filed 2026-11-10), Vanguard Portfolio Management (5.3%, Schedule 13G, filed 2026-04-29) and Vanguard Capital Management (5.03%, Schedule 13G, filed 2026-04-30).

Who are the largest shareholders of Intellia Therapeutics, Inc.?

By the share each holder's latest filing reports, the largest holders of Intellia Therapeutics, Inc. on this page are Ark Investment Management LLC (12.27%), State Street Corporation (5.6%) and Vanguard Portfolio Management (5.3%).

When did Ark Investment Management LLC buy into Intellia Therapeutics, Inc.?

The filings give report dates, not purchase dates. The earliest filing from Ark Investment Management LLC on this page is the Schedule 13G/A, filed 2026-02-03, reporting 12.27%. That earliest filing is itself an amendment, which updates an earlier report.

Is this an audit or a full list?

Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 12 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.

Want the whole picture on Intellia Therapeutics, Inc.?

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Intellia Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Intellia Therapeutics, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    19 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

Which insiders own Intellia Therapeutics, Inc. shares?

Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.

Shares outstanding: 140,358,512 as of 2026-10-30, from the company's latest SEC cover page.

How much has Intellia Therapeutics, Inc. raised?

No fundraising or offering filing from Intellia Therapeutics, Inc. is on file with us.

Red flags found

1 exit or restructuring plan on Form 8-K (latest Form 8-K, 2025-01-10).

Keep reading

More on Intellia Therapeutics, Inc. and the records around it.

Companies that share a holder

Related pages

Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.

Not for employment, credit, insurance or tenancy decisions.

Cite this page

Permanent URL: https://mentionfox.com/who-owns/intellia-therapeutics
Last updated 2026-11-15
Primary record: Schedule 13G, 2026-11-10
Who owns Intellia Therapeutics, Inc.? Owners, funding and legal record. MentionFox, 2026-11-15. https://mentionfox.com/who-owns/intellia-therapeutics